Comparison Overview
NordicInfu Care AB

NordicInfu Care AB
Gustavslundsvägen 12, Bromma / Stockholm, undefined, undefined, SE
Last Update: 11/02/2026
Nordic Infucare started its journey as an entrepreneurial company with the desire to do things differently. Mats Bergryd founded the business to offer specialized treatments in a home environment, serving patients who suffer from chronic disease. He chose that niche as ...

AUROBINDO PHARMA LTD
Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District,, Hyderabad, 500032, IN
Last Update: 03/04/2026
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, brand...
Compliance Ranges Comparison

NordicInfu Care AB







AUROBINDO PHARMA LTD






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for NordicInfu Care AB in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for AUROBINDO PHARMA LTD in 2026.
Incident History - NordicInfu Care AB (X = Date, Y = Severity)
NordicInfu Care AB cyber incidents detection timeline including parent company and subsidiaries.
Incident History - AUROBINDO PHARMA LTD (X = Date, Y = Severity)
AUROBINDO PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

NordicInfu Care AB

AUROBINDO PHARMA LTD
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.